Armata Pharmaceuticals, Inc. (ARMP)

[gator16]

NEW SUCCESS STORY !!

San Diego Union Tribune – Ancient virus’ success brings on new age of phage at UCSD
Patient received AB-SA01 to resolve a persistent heart infection, that allowed him to receive a heart transplant
The San Diego Union Tribune article highlights the case of a patient who received AmpliPhi Biosciences’ investigational bacteriophage therapeutic, AB-SA01, to help cure a Staphylococcus aureus infection located on his heart device that was not resolved by antibiotic therapy. The patient received a four-week treatment of AB-SA01 alongside antibiotics and the infection was eliminated. By resolving the infection, the patient was able to undergo a heart transplant and is now doing well.
See the link below to read the San Diego Union Tribune article:
http://www.sandiegouniontribune.com/news/health/sd-no-ucsd-phage20180619-story.html
Please also see the YouTube video below, produced by UCSD, about the patient treated with AB-SA01:

See the link below for UCSD’s announcement, establishing the Center for Innovative Phage Applications and Therapeutics (IPATH) and a description of the patient’s case: http://ucsdnews.ucsd.edu/pressrelease/turning_a_phage
Please visit the AmpliPhi Knowledge Library for more details: http://www.ampliphibio.com/science/knowledge-library/
AmpliPhi Biosciences Investor Relations Team